Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.

Health Technology Assessment : HTA
J KaiN Qureshi

Abstract

To describe and explore current practice, methods and experience of communicating carrier status information following newborn screening for cystic fibrosis (CF) and sickle cell (SC) disorders, to inform practice and further research. Three linked qualitative studies. All nine health regions in England. Child health screening coordinators in all English health regions, health professionals communicating results to parents and parents of newborn carriers. A preliminary phase of semi-structured telephone interviews with child health screening coordinators in all nine English health regions, and thematic analysis of data; semi-structured face-to-face interviews with purposeful samples of 67 family members of 51 infants identified by universal newborn screening as carriers of CF or SC with data analysis by constant comparison; and semi-structured telephone interviews, and focus groups, with a key informant sample of 16 differing health professionals currently tasked with communicating results to parents in a range of ways, with thematic analysis of data. Methods for and respondents' experiences of communication of carrier results varied considerably within and between regions, and within and between SC and CF contexts. Approaches r...Continue Reading

Citations

Jul 11, 2014·Journal of Genetic Counseling·Melissa NokeFiona Ulph
Jan 3, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Hannah M BakerAudrey Tluczek
Mar 20, 2013·Journal of Inherited Metabolic Disease·James Robert Bonham
Mar 25, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Danya F VearsLynn Gillam
Oct 9, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Jane ChudleighUNKNOWN London Cystic Fibrosis Collaboration (LCFC)
Dec 1, 2012·Patient Education and Counseling·Michael H Farrell, Stephanie A Christopher
Jun 5, 2012·Patient Education and Counseling·Lisa BradfordMichael H Farrell
Jan 29, 2013·European Journal of Medical Genetics·Annette M M Vernooij-van LangenJeannette E Dankert-Roelse
May 9, 2012·Annual Review of Genomics and Human Genetics·Beth A Tarini, Aaron J Goldenberg
Jul 30, 2014·Journal of Pediatric Hematology/oncology·Jeffrey D LebensburgerNataliya V Ivankova
Jun 10, 2010·European Journal of Human Genetics : EJHG·Fiona UlphEllen Townsend
Oct 3, 2017·Health Technology Assessment : HTA·Fiona UlphTina Lavender
Oct 6, 2018·MDM Policy & Practice·Stuart James WrightKatherine Payne
Oct 21, 2004·The Cochrane Database of Systematic Reviews·S OliverR Stewart
Dec 2, 2018·International Journal of Neonatal Screening·Elza CloeteFrank H Bloomfield
Jan 25, 2020·Clinical Diabetes : a Publication of the American Diabetes Association·Anna Cronin de ChavezDonald C Whitelaw

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.